Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 820 of 6351
-
AI heart scan software aims to spot dangerous blockages without invasive probes
Diagnosis CompletedThe goal of this study is to evaluate the diagnostic accuracy of a novel plaque-based coronary CT angiography (CCTA) fractional flow reserve (FFRct) software device for the estimation of invasive fractional flow reserve (FFR). Researchers will compare the Elucid plaque-based FFR…
Sponsor: Elucid Bioimaging Inc. • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC
-
Can a classroom tool ease teen anxiety and depression? new study aims to find out.
Symptom relief OngoingAdolescence is a developmental period of significant risk for anxiety, depressive symptoms, and suicidality, and the investigators propose to target key peer-based risk and protective factors using Cooperative Learning (CL). CL is a small-group instructional approach that can enh…
Sponsor: University of Oregon • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
New drug combo helps High-Risk kidney cancer patients avoid full kidney removal
Disease control CompletedThrough the neoadjuvant treatment with a combination of Cadonilimab and Lenvatinib, it enabled the successful and safe implementation of partial nephrectomy in patients with localized renal cancer, who had indications for nephron-sparing surgery but faced considerable difficulty …
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New cocktail of drugs shows promise for Hard-to-Treat throat cancer
Disease control OngoingFirst-diagnosed metastasis or recurrence/metastasis NPC Patients will be treated with anlotinib, penpulimab and capecitabine.
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Personalized cell therapy takes on childhood cancers
Disease control Recruiting nowThis is a pediatric basket study to investigate the safety and efficacy of afamitresgene autoleucel in HLA-A\*02 eligible and MAGE-A4 positive subjects aged 2-17 years of age with advanced cancers.
Phase 1/2 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Talk to your computer: could a chatbot detect Alzheimer's before you forget?
Diagnosis By invitation onlyEarly cognitive disorders diagnosis is becoming increasingly important due to population aging. The most common causes include Alzheimer's disease and frontotemporal dementia. These diseases are also manifested by changes in speech. NLP allows us to identify and classify these ch…
Sponsor: Faculty Hospital Kralovske Vinohrady • Aim: Diagnosis
Last updated Jun 27, 2026 12:26 UTC
-
Blood-Derived shot may mend Worn-Out knees
Disease control Recruiting nowTo evaluate the safety and effectiveness of PRP injection therapy in the repair of osteoarthritis and periarticular soft tissue injury through a single-center, exploratory clinical study, and to provide a more reliable basis for the treatment of joint injury.
Sponsor: Xijing Hospital • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Seaweed extract may tackle fatty liver Disease—A trial puts it to the test
Disease control CompletedThis randomized, double-blind, placebo-controlled study evaluated whether Gdue®, a nutraceutical containing extracts of the brown algae Ascophyllum nodosum and Fucus vesiculosus together with chromium picolinate, could improve metabolic health and liver fat when added to a hypoca…
Sponsor: University of Genova • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
A simple baking soda pill may protect dialysis Patients' blood vessels
Disease control Completedthe investigators will test the effect of interdialytic metabolic acidosis correction on vascular calcification in hemodialysis patients
Phase 1 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a common supplement ease a rare liver disease?
Disease control CompletedThe aim of this study is to investigate clinical effects (liver biochemistries, health-related quality of life, liver stiffness) and underlying mechanisms of hepatoprotection of S-adenosylmethionine in patients with primary sclerosing cholangitis. The study will be performed in a…
Sponsor: Medical University of Warsaw • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can laser or Air-Polishing boost gum disease treatment?
Disease control CompletedThis randomized interventional study aims to compare the clinical and biochemical effects of conventional non-surgical periodontal therapy (NSPT), adjunctive diode laser therapy, and guided biofilm therapy (GBT) in patients with Stage 3 periodontitis. Participants are allocated …
Sponsor: Ataturk University • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New drug bitopertin offers hope for sunlight pain relief in rare blood disorders
Disease control By invitation onlyThis is an open-label, long-term extension study to investigate the safety, tolerability and efficacy of DISC-1459 in participants with EPP.
Phase 2/3 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New heart drug aficamten aims to boost exercise and quality of life in HCM patients
Symptom relief OngoingThis clinical trial will study the effects of aficamten (versus placebo) on the quality of life, exercise capacity, and clinical outcomes of patients with non-obstructive hypertrophic cardiomyopathy.
Phase 3 • Sponsor: Cytokinetics • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Antibiotic-Releasing bone graft aims to fight infection and regrow bone in one step
Disease control Recruiting nowThis is a pivotal, prospective, multi-center, randomized, concurrent control, patient and assessor-blinded study with two arms: a treatment arm (where subjects will be treated with the EP Granules + Tobramycin (EP G + T) investigational device, a combination device + antibiotic, …
Sponsor: Elute, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New drug combo targets tough pancreatic cancer in early trial
Disease control OngoingThis study is an open-label, multicentre, Phase 1b trial designed to determine the safety, tolerability, efficacy, PK, pharmacodynamics (PD) and proof-of-concept of OMO-103 in combination with the standard regimen gemcitabine/nab-paclitaxel in patients with metastatic pancreatic …
Phase 1 • Sponsor: Peptomyc S.L. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New hope for PBC patients: drug aims to slow liver damage
Disease control Recruiting nowThe participants of this study will have confirmed Primary Biliary Cholangitis (PBC) and cirrhosis (scarring of the liver). PBC is a slowly progressive disease, characterised by damage to the bile ducts in the liver, leading to a build-up of bile acids which causes further damag…
Phase 3 • Sponsor: Ipsen • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for kids with rare immune disease: leniolisib trial launches
Disease control OngoingThis is a 2-part, prospective, open-label, single arm, multicenter study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PDx), and efficacy of leniolisib in at least 15 pediatric patients (aged 1 to 6 years) with activated phosphoinositide 3-kinase …
Phase 3 • Sponsor: Pharming Technologies B.V. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo inhaler aims to cut severe asthma Flare-Ups
Disease control OngoingThe primary objective of the study is to assess the efficacy of high dose fluticasone propionate (Fp)/albuterol sulfate (ABS) integrated electronic module multidose dry powder inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs). Seconda…
Phase 3 • Sponsor: Teva Branded Pharmaceutical Products R&D LLC • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Spinal implant upgrade aims to get people walking again
Disease control Recruiting nowThe purpose of this pre-market clinical study is to assess the preliminary safety and efficacy of the ARC Therapy using the ARC-IM Lumbar System at supporting mobility in participants who have previously received a spinal array and an implantable pulse generator (IPG) either thro…
Sponsor: Ecole Polytechnique Fédérale de Lausanne • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a glass of Alcohol-Free wine boost your brain?
Disease control PausedPrevious studies have shown that polyphenol-rich foods can positively affect cognitive functions, memory, and mood in humans. We hypothesize that both acute and chronic intake of muscadine wine polyphenols will improve cognitive performance and mood through regulating the HPA axi…
Sponsor: University of Florida • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC